3D Bioprinted Organoids and Tissue Models

At Polbionica, we develop advanced 3D-bioprinted organoids and tissue models that closely replicate the body’s biological environment, including complex tumor microenvironments.

Our technologies enhance the reliability of preclinical research on novel therapies, enable precise toxicity assessment, and support early-stage drug development. At the same time, they contribute to reducing the use of animal models in accordance with the 3R principle (Replace, Reduce, Refine).

Category:

Description

Our Offer Includes:
  • Ready-to-use and customized 3D models for preclinical research:
    • Pancreatic islet models (organ-on-a-chip systems)
    • Liver organoids and hepatocellular carcinoma models
    • Perfusable endothelial vascular models
Applications of Our Models
  • Toxicity and safety testing of chemical and biological compounds
  • Drug screening and therapeutic candidate evaluation
  • Analysis of metastasis mechanisms
  • Biomarker discovery and liquid biopsy research
  • Personalized medicine approaches using patient-derived cells (e.g., iPSCs, primary cells)

We also design fully customized models tailored to individual client requirements, including:

  • Models aligned with specific cell lines, biomarkers, and therapeutic strategies
  • Multicellular constructs reflecting complex tissue architecture
  • Patient-derived organoids printed from patient-specific material (PDOs)

 

 

Want to learn more, contact us: sale@polbionica.com